Cargando…
Development and Validation of a Prognostic Gene Signature in Clear Cell Renal Cell Carcinoma
Clear cell renal cell carcinoma (ccRCC), one of the most common urologic cancer types, has a relatively good prognosis. However, clinical diagnoses are mostly done during the medium or late stages, when mortality and recurrence rates are quite high. Therefore, it is important to perform real-time in...
Autores principales: | Zhan, Chuanchuan, Wang, Zichu, Xu, Chao, Huang, Xiao, Su, Junzhou, Chen, Bisheng, Wang, Mingshan, Qi, Zhihong, Bai, Peiming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8098777/ https://www.ncbi.nlm.nih.gov/pubmed/33968978 http://dx.doi.org/10.3389/fmolb.2021.609865 |
Ejemplares similares
-
Analyzing and Validating the Prognostic Value of a TNF-Related Signature in Kidney Renal Clear Cell Carcinoma
por: Zhang, Wenhao, et al.
Publicado: (2021) -
Hub Long Noncoding RNAs with m6A Modification for Signatures and Prognostic Values in Kidney Renal Clear Cell Carcinoma
por: Lin, Gaoteng, et al.
Publicado: (2021) -
Integrative Analysis of Immune-Related Genes in the Tumor Microenvironment of Renal Clear Cell Carcinoma and Renal Papillary Cell Carcinoma
por: Zheng, Bin, et al.
Publicado: (2021) -
Identification of Mast Cell-Based Molecular Subtypes and a Predictive Signature in Clear Cell Renal Cell Carcinoma
por: Liu, Hanxiang, et al.
Publicado: (2021) -
Comprehensive analysis of LAMC1 expression and prognostic value in kidney renal papillary cell carcinoma and clear cell carcinoma
por: Bai, Jianrong, et al.
Publicado: (2022)